Streetbeat News

Products Services

ABBV

JNJ

TAK

The FDA has approved AbbVie's Rinvoq (upadacitinib) as the first oral treatment for moderately to severely active Crohn's disease patients. This marks the seventh FDA approval for Rinvoq across rheumatology, dermatology, and gastroenterology. Rinvoq competes with other biologics such as Johnson & Johnson's Stelara and Takeda Pharmaceutical's Entyvio.

Portfolio Pulse from Vandana Singh

May 19, 2023 | 12:13 pm

HOLX

Hologic Inc. (NASDAQ:HOLX) has received FDA clearance for its Panther Fusion SARS-CoV-2/Flu A/B/RSV assay, a molecular diagnostic test that detects and differentiates four prevalent respiratory viruses. The test runs on the fully automated Panther Fusion system and launches with the new RespDirect collection kit.

Portfolio Pulse from Happy Mohamed

May 19, 2023 | 12:09 pm

AMRS

Amyris has signed an exclusive license agreement with Croda International for the supply of sustainable squalene. Under the agreement, Amyris will manufacture and supply squalene to Croda, who will market, distribute, and sell it for use in human and veterinary vaccines, drug delivery systems, and nucleic acid delivery systems.

Portfolio Pulse from Happy Mohamed

May 19, 2023 | 12:06 pm

TSHA

Taysha Gene Therapies presents preclinical data on TSHA-102 for Rett syndrome, demonstrating cellular regulation of MeCP2 expression in key mouse models. The data suggests TSHA-102, engineered with miRARE technology, avoided toxic overexpression of MeCP2. Dosing of the first adult patient in the Phase 1/2 REVEAL trial is expected in Q2 2023.

Portfolio Pulse from Happy Mohamed

May 19, 2023 | 12:05 pm

TMO

The FDA has approved Thermo Fisher Scientific's immunoassay as the first and only blood-based biomarker test to assess preeclampsia. This approval could lead to increased demand for the company's diagnostic products.

Portfolio Pulse from Benzinga Newsdesk

May 19, 2023 | 12:04 pm

TM

Toyota Motor Corp (NYSE:TM) unveiled the fourth-generation Tacoma truck, set to be available in early 2024. The company aims to maintain its leadership in the mid-size pickup truck market. The new Tacoma features new designs, two turbocharged engine options, and an i-FORCE MAX hybrid model.

Portfolio Pulse from Lekha Gupta

May 19, 2023 | 11:42 am

BSGM

BioSig Technologies' PURE EP platform has been used by researchers to achieve equal lesion quality and dimension in a third of the time compared to conventional methods.

Portfolio Pulse from Benzinga Newsdesk

May 19, 2023 | 11:33 am

GOOG

GOOGL

YouTube, owned by Alphabet Inc. (NASDAQ:GOOG) (NASDAQ:GOOGL), generated $40 billion in revenue in the past 12 months, primarily driven by advertisements. The platform recently introduced 30-second unskippable ads for televisions and implemented measures to prohibit ad-blockers, potentially pushing users towards paid subscriptions or forcing them to watch unskippable ads.

Portfolio Pulse from Ananya Gairola

May 19, 2023 | 11:30 am

ALV

NIO

TSLA

Chinese EV maker NIO has invested $145.42 million for a 19.9% stake in nuclear fusion startup Neo Fusion. Nio Capital, founded by NIO's CEO, invested $73.81 million for a 10.1% share. NIO also partnered with Autoliv China to develop safety products for electric vehicles and sustainable technologies.

Portfolio Pulse from Anusuya Lahiri

May 19, 2023 | 11:29 am

BROS

CELH

ONON

CNBC Mad Money host Jim Cramer praised On Holding AG (NYSE:ONON), calling it the 'fastest growing sneaker company in the world.' The Swiss sneaker maker, backed by tennis legend Roger Federer, recently reported a 78% sales growth in Q1, exceeding consensus estimates. Cramer also recommended energy drink maker Celsius Holdings Inc. (NASDAQ:CELH) and coffee chain Dutch Bros Inc. (NYSE:BROS) as top picks for young investors.

Portfolio Pulse from Aveek Bhowmik

May 19, 2023 | 11:25 am